July 29 ( Sat ) - July 30 ( Sun ) , 2023

Taipei Veterans General Hospital, Taipei, Taiwan

Exhibitor Floor Plan


Date - July 2930, 2023

Venue - Taipei Veterans General Hospital

July 29
Chieh-Shou Hall Chih-Teh Building1stConference Room Chih-Teh Building2ndConference Room Chih-Teh Building3rdConference Room Medical Science & Technology Building Conference Room
08:00~15:00 Registration
08:20~08:30 Opening remarks
08:30~10:10 Live demo
Evidence-based knowledge in the role of endoscopy for bariatric therapy
Cold Revolution: Lessons learned from the TACOS trial

* English Session

Fecal microbiota transplantation (FMT): Where Are We, Where Are We Going?
Video Contest
Part (A)

Juror (sorted by surname)

Ming-Jen Chen

MacKay Memorial Hospital

Yang-Yuan Chen

Changhua Christian Hospital

Jiing-Chyuan Luo

Taipei Veterans General Hospital

No. Time Presenter Affiliation Topic
A01 08:3008:42 Bo-Huan Chen Chang Gung Memorial Hospital, Linkou Anti-reflux mucosectomy with cardia-plasty for refractory gastroesophageal reflux patient
A02 08:4208:54 Chung-Ying Lee Shuang Ho Hospital Snare-tipped Endoscopic Radical Incision and Cutting (STERIC) for Post-operative Colorectal Anastomotic Stricture
A03 08:5409:06 Wei-Yuan Chang National Taiwan University Cancer Center IEE-based diagnosis of T1 colorectal cancer
A04 09:0609:18 Chia-Chien Kang MacKay Memorial Hospital Overtube-assisted Implantation of Capsule Endoscopy
A05 09:1809:30 Yen-Wen Huang MacKay Memorial Hospital Deep enteroscopy for removal a huge ileal bezoar
A06 09:3009:42 Yu-Chi Li Kaohsiung Chang Gung Memorial Hospital Application of double-clips traction assisted ESD in cecum LST involving appendix orifice
A07 09:4209:54 Ming-Ching Yuan Chiayi Christian Hospital Expanding rather than closing the wound can rescue the endoscopic procedure when massive bleeding occurs during endoscopic submucosal dissection
A08 09:5410:06 Hung-Ting Chung Cathay General Hospital Endocuff & aetherAI(Endo)
10:0610:20 Break
10:10~10:20 Break
10:20~12:00 Live demo
Advances in endoscopic management of GI neoplasms
Updates from Taiwan CRC Screening Program
Endotherapy for difficult strictures

* English Session

Video Contest
Part (B)

Juror (sorted by surname)

Chien-Hua Chen

Show Chwan Memorial Hospital

Chun-Jung Lin

Chang Gung Memorial Hospital, Linkou

I-Chen Wu

Kaohsiung Medical University Hospital

No. Time Presenter Affiliation Topic
B01 10:2010:32 Meng-Ying Lin National Cheng Kung University Hospital A useful rescue of intra-peritoneal deployment metallic stent during EUS HGS
B02 10:3210:44 Pin-Chun Huang China Medical University Hospital Fully covered self-expended metallic stent (SEMS) for biliary varices bleeding
B03 10:4410:56 Kuei-Chang Kuo Far Eastern Memorial Hospital EUS-guided LAMS and peroral cholecystoscopy for gallstone clearance in a 85-year-old man with acute calculous cholecystitis
B04 10:5611:08 Kuan-Chih Chen Far Eastern Memorial Hospital Detection of hepatocellular carcinoma with bile duct tumor thrombus by peroral cholangioscopy
B05 11:0811:20 Yi-Jun Liao Taichung Veterans General Hospital EUS-BD in management of malignant biliary obstruction
B06 11:2011:32 Wan-Ting Yeh Changhua Christian Hospital 膽道內射頻燒灼術在遠端惡性膽道阻塞的應用
B07 11:3211:44 Pei-Shan Wu Taipei Veterans General Hospital Biliary RFA for palliative perihilar tumor treatment
12:10~13:30 S1
Yuan Yu
13:30~15:10 Live demo
Endoluminal intervention for motility disorders : an update
Endoscopy in inflammatory bowel disease
Cutting edge of interventional EUS
15:10~15:20 Break
15:20~17:00 Live demo
The development of artificial intelligence in gastro-intestinal endoscopy: present and future
Small intestinal tumors
Recent advancement in interventional ERCP and EUS
Endoscopic practice in Primary Care

July 30
Chieh-Shou Hall Chih-Teh Building1stConference Room Chih-Teh Building2ndConference Room Chih-Teh Building3rdConference Room Medical Science & Technology Building Conference Room
08:00~10:00 Registration
08:20~09:10 SL1
Special lecture (I)Prof. Yutaka Saito Updates on Endoscopic Submucosal Dissection (ESD) for Colorectal Lesions
Updates on Endoscopic Submucosal Dissection (ESD) for Colorectal Lesions

Yutaka Saito

National Cancer Center Hospital, Tokyo, JAPAN

Since its inclusion in insurance coverage in April 2012, colorectal ESD has rapidly gained popularity throughout Japan. We have presented the effectiveness of traction (Sinker ESD) and CO2 insufflation in colorectal ESD. Furthermore, we reported on 200 cases from NCCH and 1,111 cases from multi centers in Japan, demonstrating the clinical efficacy of short-term results.

During DDW2022, the French multicenter ESD group reported the short-term outcomes of a randomized controlled trial (RCT) comparing colorectal ESD and EMR. The results showed that ESD had superior short-term outcomes in terms of recurrence rate.

To study long-term prognosis, we have established CREATE-J, a multicenter group in Japan. We have also reported on the efficacy of colorectal ESD in long-term outcomes in Gastroenterology. The curative resection criteria of the JSCCR guidelines for T1 colorectal cancer have proven to be appropriate.

Regarding ESD techniques, we have presented the effectiveness of the Bipolar device and the IT knife nano with an insulated tip. The Pocket Creation Method (PCM) and bridge formation methods have also been reported, leading to widespread adoption of safe strategies for colorectal ESD. Traction devices are now commercially available worldwide, further enhancing the safety and reliability of colorectal ESD.

However, in Western countries, the clinical utility of ESD in the rectum is gaining recognition, while there is ongoing debate regarding the sufficiency of piecemeal resection in the proximal colon. The ACE study group data suggests a higher frequency of submucosal (SM) invasion in the rectum, but our CREATE-J data demonstrates no difference in the frequency of SM invasion between the colon and rectum. This discrepancy is likely due to case selection bias. Some argue that the concept of intramucosal carcinoma does not exist in the West and that only SM1 lesions should be selectively treated by ESD. However, even with the use of magnifying endoscopes, this distinction is challenging. Therefore, not only SM1 lesions but also M carcinoma, which is a precursor lesion of SM carcinoma, should be considered as an indication for ESD.

Currently, within the framework of the WEO CRC screening committee, a subgroup focusing on colorectal ESD/EMR has been formed and is deliberating on the Statement. The ASGE is also planning to develop guidelines for colorectal ESD.

It is desirable to promote evidence-based treatment strategies for colorectal tumors.

09:10~10:00 SL2
Special lecture (II)Prof. Naohisa Yahagi Optimization of endoscopic resection for duodenal lesions
Optimization of endoscopic resection for duodenal lesions

Naohisa Yahagi

Keio University School of Medicine, JAPAN

Although the frequency of duodenal tumors has been increasing in recent years, the absolute number of duodenal tumors is relatively small and experience is limited, therefore, diagnostic and therapeutic strategies have not yet been established. Many of these tumors are benign and do not change much even after long term follow-up, thus it was previously thought that the need for treatment may not be very important. However, there have been cases of adenomas developing into advanced cancer over time, and when surgical treatment is necessary, it involves an extremely invasive procedure such as pancreaticoduodenectomy, therefore, the trend is toward endoscopic resection of even small tumors as soon as they are detected. In the duodenum there were various problems that have hindered its widespread use, including poor scope maneuverability, difficulty in obtaining a good protrusion even with local injection, thin walls which increases risk of perforation, as well as an extremely high risk of delayed complications such as bleeding and perforation due to presence of pancreatic juice and bile.

In our previous studies, we have found that most tumors that are diffusely WOS (white opaque substance) positive and less than 13 mm in size are low grade intestinal type adenomas, and we believe that CFP and CSP can be performed for these lesions at primary care center. On the other hand, WOS negative tumors or tumors greater than 13 mm have an increased risk of malignancy, but for the lesions up to 20 mm can be resected by EMR or UEMR or UEMR with partial injection. But importantly, the risk of complication becomes higher in resection procedures with high frequency energy, it is essential to have an adequate backup system for emergency. For this reason, these procedures should be performed at a regional core medical center with a full biliopancreatic team and surgical team. Obviously, lesions greater than 20 mm are difficult to resect with snare techniques, thus ESD or Laparoscopy and Endoscopy Cooperative Surgery (LECS) are necessary. However, different knowledge and techniques are needed in the duodenum than in other organs. We should keep in mind that we should not start doing duodenal ESD simply because somebody has sufficient experience of ESD in other organs, since it is very different and even dangerous. Fortunately, the absolute number of large lesions greater than 20 mm is limited. Those treatments should be centralized in advanced care centers which have sufficient experience and skills.

Special lecture (III)Prof. Yuichi Mori Artificial intelligence in endoscopy-time for clinical application?
Artificial intelligence in endoscopy-time for clinical application?

Yuichi Mori

University of Oslo, Norway

Showa University Northern Yokohama Hospital, Japan

Adoption of artificial intelligence (AI) in clinical medicine is revolutionizing daily practice. In the field of colonoscopy, major endoscopy manufacturers have already launched their own AI products on the market with regulatory approval in Europe, Asia, and the US. This commercialization is strongly supported by positive evidence that has been recently established through rigorously designed prospective trials and randomized controlled trials. Given that reliable evidence is emerging, together with active commercialization, this seems to be a good time for us to review and discuss the current status of AI in endoscopy. The presentation will be focused on the advantages and possible drawbacks of AI tools and explore their future potential including the role of cancer screening programmes, innovative therapeutic approaches, and guideline recommendations.

10:00~10:20 Break
10:20~11:10 CS1
Chairman speechProf. Ching-Liang Lu GI Endoscopy in FGID and health information technology in endoscopy suites
GI Endoscopy in FGID and health information technology in endoscopy suites

Ching-Liang Lu

Taipei Veterans General Hospital

  1. Functional gastrointestinal disorders (FGIDs), or disorder of brain-gut interaction (DBIG), manifest as troublesome symptoms arising from the gastrointestinal (GI) tract. FGIDs are highly prevalent and bring a significant burden to the individual patient and society. The most frequent encountered FGIDs are irritable bowel syndrome (IBS) and functional dyspepsia (FD), and gastroesophageal reflux disorder (GERD). In daily practice, endoscopy plays an important role during the FGID diagnostic process. Typical/atypical GERD and dyspeptic symptoms are the major indications for esophagogastroduodenoscopy (EGD). When facing the patients manifesting IBS symptoms, clinicians are particularly concerned about missing colorectal cancer (CRC) or inflammatory bowel diseases (IBDs), leading to colonoscopy examination. Nevertheless, no organic lesions could be identified in most these EGD and colonoscopy. Therefore, we should pay attention on with the limitations and usefulness of endoscopy for our FGID patients, who constitute the majorities of the outpatients in our daily practice.
  2. Computer aided diagnosis (CAD)-based artificial intelligence (AI) algorithm has been proved to detect colon polyp and differentiate between adenomatous and hyperplastic polyp accurately. With the application of AI during colonoscopy, the GI endoscopists could have higher polyp or adenoma detection rate without increased examination time. CAD-AI colonoscopy for polyp detection may serve as a standardized practice in near future. AI may also be applied for detection of abnormalities other than polyps and combined with auto reporting system. We have used colonoscopy pictures obtained from the databank in the Endoscopy center of Taipei Veterans General Hospital to train AI algorithm to detect anatomic landmark and different types of colonic lesions (polyp, diverticulum, and colon cancers) during colonoscopy examination. We also developed an AI algorithm to evaluate the colon cleanliness in measuring the preparation quality in colonoscopy. We further tried to set up an alert system to advice the endoscopists to achieve an adequate withdrawn time during colonoscopy. These models may help for future fellowship training and clinical practice in performing colonoscopy. We hope such development in CAD-AI colonoscopy can be of benefits in improving the quality of care for our patients.


11:10~12:00 SL4
Special lecture(IV)Prof. Haruhiro InoueThird space endoscopy- current status and future